Senior Clinical Program Leader - Obesity & Liver

In this role, you drive early-phase obesity and liver programs from strategy through execution, leading cross-functional teams to advance therapies. You’ll influence regulatory strategy and contribute to Medical Affairs plans, shaping evidence generation and decision-making across development. You will mentor other clinical leads and act as a delegate for the Clinical Development Lead when needed. This position offers the chance to impact global patient care through scientific leadership and collaboration.

• Design and oversee Phase I–II clinical development plans for obesity and liver indications
• Lead cross-functional teams across trial operations, biostatistics, biomarkers, and patient safety to ensure high-quality execution
• Manage setup, conduct, and data readout of trials in collaboration with the Clinical Trial Lead
• Provide input to regulatory strategy and contribute to briefing documents and regulatory responses
• Contribute to Medical Affairs strategy and deliverables (e.g., Integrated Evidence Plan) with Medical Advisors
• Evaluate external opportunities to strengthen the pipeline and inform decision-making
• Supervise and mentor other Clinical Program Leads within the program/asset and serve as a delegate for the Clinical Development Lead

• MD degree with extensive clinical and scientific experience in metabolic diseases, cardiovascular, renal, or internal medicine
• Long-term experience in clinical drug development in the pharmaceutical industry or equivalent academic clinical research
• Strong leadership and ability to motivate cross-functional teams
• Proven ability to influence and collaborate with diverse stakeholders
• Skilled in presenting scientific content and facilitating cross-functional discussions
• High initiative, strategic thinking, and team orientation
• Excellent English communication skills (written and verbal)

• leadership
• cross-functional collaboration
• communication
• clinical drug development
• regulatory strategy input
• trial design and execution (Phase I–II)